For many survivors who need a valve replacement, one of the biggest questions is how long the new valve will last. This recent HeartValveSurgery.com update shares encouraging 10-year results from the COMMENCE trial, suggesting strong durability for the INSPIRIS RESILIA tissue valve and low rates of repeat surgery. It is hopeful news for survivors looking for reassurance about long-term outcomes.
News